Mesenchymal Stem Cells in a Mouse Model of Multiple System Atrophy
Author Information
Author(s): Stemberger Sylvia, Jamnig Angelika, Stefanova Nadia, Lepperdinger Günter, Reindl Markus, Wenning Gregor K.
Primary Institution: Innsbruck Medical University, Innsbruck, Austria
Hypothesis
Can intravenous application of mesenchymal stem cells (MSCs) improve neuroprotection and modulate neuroinflammation in a transgenic mouse model of multiple system atrophy (MSA)?
Conclusion
Intravenously infused MSCs showed neuroprotective effects but did not improve behavioral outcomes in the MSA mouse model.
Supporting Evidence
- MSCs showed a significant recovery of TH+ neurons in the substantia nigra pars compacta.
- Behavioral tests showed no significant improvement in motor function after MSC treatment.
- Significant downregulation of pro-inflammatory cytokines was observed in the MSC treatment group.
Takeaway
Researchers tested if injecting special cells called MSCs could help mice with a brain disease called MSA. The cells helped protect some brain cells but didn't make the mice better at moving.
Methodology
MSCs were injected into aged (PLP)-αSYN transgenic mice, and their effects on behavior, neuroprotection, and neuroinflammation were analyzed.
Potential Biases
Potential bias due to the small sample size and the specific age of the mice used.
Limitations
The study had a low survival rate of MSCs post-injection and did not assess long-term effects.
Participant Demographics
Aged (PLP)-αSYN transgenic mice, 18 months old.
Statistical Information
P-Value
0.036
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website